VRCA
Verrica Pharmaceuticals Inc. Common StockRecent alerts on VRCA
All signals →
News
Verrica Posts Profit in Fiscal Q2
14d ago
Scanner
Unusual buy pressure (6.4x avg, 74% up-volume, +11.9% / +0.64 intraday, above VWAP)
83d ago
SEC filing
VRCA Reports $35.6M Revenue, $15.3M YCANTH Net, +130% YoY, 99% Unit Growth, Phase 3 Advances, Debt-Free, Cash to 2027
83d ago
News
Prabowo Names Former Central Banker as Deputy Finance Minister
117d ago
News
Verrica Pharmaceuticals Announces First Patient Dosed in Phase 3 Program Evaluating YCANTH® (VP-102) for the Treatment of Common Warts
146d ago
Get push alerts for VRCA
Add it to your watchlist in the app and receive every signal the moment it fires.
Download for iOS